Literature DB >> 20371621

Metabolomic profiling can predict which humans will develop liver dysfunction when deprived of dietary choline.

Wei Sha1, Kerry-Ann da Costa, Leslie M Fischer, Michael V Milburn, Kay A Lawton, Alvin Berger, Wei Jia, Steven H Zeisel.   

Abstract

Choline is an essential nutrient, and deficiency causes liver and muscle dysfunction. Common genetic variations alter the risk of developing organ dysfunction when choline deficient, probably by causing metabolic inefficiencies that should be detectable even while ingesting a normal choline-adequate diet. We determined whether metabolomic profiling of plasma at baseline could predict whether humans will develop liver dysfunction when deprived of dietary choline. Fifty-three participants were fed a diet containing 550 mg choline/70 kg/d for 10 d and then fed < 50 mg choline/70 kg/d for up to 42 d. Participants who developed organ dysfunction on this diet were repleted with a choline-adequate diet for > or = 3 d. Plasma samples, obtained at baseline, end of depletion, and end of repletion, were used for targeted and nontargeted metabolomic profiling. Liver fat was assessed using magnetic resonance spectroscopy. Metabolomic profiling and targeted biochemical analyses were highly correlated for the analytes assessed by both procedures. In addition, we report relative concentration changes of other small molecules detected by the nontargeted metabolomic analysis after choline depletion. Finally, we show that metabolomic profiles of participants when they were consuming a control baseline diet could predict whether they would develop liver dysfunction when deprived of dietary choline.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20371621      PMCID: PMC2909293          DOI: 10.1096/fj.09-154054

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  69 in total

1.  Statistical significance for genomewide studies.

Authors:  John D Storey; Robert Tibshirani
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-25       Impact factor: 11.205

2.  Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia.

Authors:  Alan D Attie; Ronald M Krauss; Mark P Gray-Keller; Alison Brownlie; Makoto Miyazaki; John J Kastelein; Aldons J Lusis; Anton F H Stalenhoef; Jonathan P Stoehr; Michael R Hayden; James M Ntambi
Journal:  J Lipid Res       Date:  2002-11       Impact factor: 5.922

3.  The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes.

Authors:  Z M Yao; D E Vance
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

4.  Effect of choline deficiency on S-adenosylmethionine and methionine concentrations in rat liver.

Authors:  S H Zeisel; T Zola; K A daCosta; E A Pomfret
Journal:  Biochem J       Date:  1989-05-01       Impact factor: 3.857

5.  Periconceptional dietary intake of choline and betaine and neural tube defects in offspring.

Authors:  Gary M Shaw; Suzan L Carmichael; Wei Yang; Steve Selvin; Donna M Schaffer
Journal:  Am J Epidemiol       Date:  2004-07-15       Impact factor: 4.897

6.  An integrated reverse functional genomic and metabolic approach to understanding orotic acid-induced fatty liver.

Authors:  Julian L Griffin; Stephanie A Bonney; Chris Mann; Abdul M Hebbachi; Geoff F Gibbons; Jeremy K Nicholson; Carol C Shoulders; James Scott
Journal:  Physiol Genomics       Date:  2004-04-13       Impact factor: 3.107

7.  Creatinine transport by basolateral organic cation transporter hOCT2 in the human kidney.

Authors:  Yumiko Urakami; Naoko Kimura; Masahiro Okuda; Ken-ichi Inui
Journal:  Pharm Res       Date:  2004-06       Impact factor: 4.200

8.  Elevated serum creatine phosphokinase in choline-deficient humans: mechanistic studies in C2C12 mouse myoblasts.

Authors:  Kerry-Ann da Costa; Mihaela Badea; Leslie M Fischer; Steven H Zeisel
Journal:  Am J Clin Nutr       Date:  2004-07       Impact factor: 7.045

9.  Quantitation of choline and its metabolites in tissues and foods by liquid chromatography/electrospray ionization-isotope dilution mass spectrometry.

Authors:  Hasan Koc; Mei-Heng Mar; Asoka Ranasinghe; James A Swenberg; Steven H Zeisel
Journal:  Anal Chem       Date:  2002-09-15       Impact factor: 6.986

10.  Multiclass classification of microarray data with repeated measurements: application to cancer.

Authors:  Ka Yee Yeung; Roger E Bumgarner
Journal:  Genome Biol       Date:  2003-11-24       Impact factor: 13.583

View more
  53 in total

1.  Hydroxysteroid 17-β dehydrogenase 13 variant increases phospholipids and protects against fibrosis in nonalcoholic fatty liver disease.

Authors:  Panu K Luukkonen; Taru Tukiainen; Anne Juuti; Henna Sammalkorpi; P A Nidhina Haridas; Onni Niemelä; Johanna Arola; Marju Orho-Melander; Antti Hakkarainen; Petri T Kovanen; Om Dwivedi; Leif Groop; Leanne Hodson; Amalia Gastaldelli; Tuulia Hyötyläinen; Matej Orešič; Hannele Yki-Järvinen
Journal:  JCI Insight       Date:  2020-03-12

2.  Fecal metabolomics: assay performance and association with colorectal cancer.

Authors:  James J Goedert; Joshua N Sampson; Steven C Moore; Qian Xiao; Xiaoqin Xiong; Richard B Hayes; Jiyoung Ahn; Jianxin Shi; Rashmi Sinha
Journal:  Carcinogenesis       Date:  2014-07-18       Impact factor: 4.944

3.  Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH.

Authors:  Gabriella V Hernandez; Victoria A Smith; Megan Melnyk; Matthew A Burd; Kimberly A Sprayberry; Mark S Edwards; Daniel G Peterson; Darin C Bennet; Rob K Fanter; Daniel A Columbus; Juan P Steibel; Hunter Glanz; Chad Immoos; Margaret S Rice; Tasha M Santiago-Rodriguez; Jason Blank; Jennifer J VanderKelen; Christopher L Kitts; Brian D Piccolo; Michael R La Frano; Douglas G Burrin; Magdalena Maj; Rodrigo Manjarin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-31       Impact factor: 4.052

4.  The "Virtual Digital Twins" Concept in Precision Nutrition.

Authors:  Kalliopi Gkouskou; Ioannis Vlastos; Petros Karkalousos; Dimitrios Chaniotis; Despina Sanoudou; Aristides G Eliopoulos
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

5.  Untargeted LC-MS metabolomics of bronchoalveolar lavage fluid differentiates acute respiratory distress syndrome from health.

Authors:  Charles R Evans; Alla Karnovsky; Melissa A Kovach; Theodore J Standiford; Charles F Burant; Kathleen A Stringer
Journal:  J Proteome Res       Date:  2013-12-09       Impact factor: 4.466

6.  Serum biomarkers of habitual coffee consumption may provide insight into the mechanism underlying the association between coffee consumption and colorectal cancer.

Authors:  Kristin A Guertin; Erikka Loftfield; Simina M Boca; Joshua N Sampson; Steven C Moore; Qian Xiao; Wen-Yi Huang; Xiaoqin Xiong; Neal D Freedman; Amanda J Cross; Rashmi Sinha
Journal:  Am J Clin Nutr       Date:  2015-03-11       Impact factor: 7.045

Review 7.  Choline's role in maintaining liver function: new evidence for epigenetic mechanisms.

Authors:  Mihai G Mehedint; Steven H Zeisel
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2013-05       Impact factor: 4.294

Review 8.  Metabolic crosstalk between choline/1-carbon metabolism and energy homeostasis.

Authors:  Steven H Zeisel
Journal:  Clin Chem Lab Med       Date:  2013-03-01       Impact factor: 3.694

9.  Choline supply of preterm infants: assessment of dietary intake and pathophysiological considerations.

Authors:  Wolfgang Bernhard; Anna Full; Jörg Arand; Christoph Maas; Christian F Poets; Axel R Franz
Journal:  Eur J Nutr       Date:  2012-09-09       Impact factor: 5.614

10.  Highlights of the 2012 Research Workshop: Using nutrigenomics and metabolomics in clinical nutrition research.

Authors:  Steven H Zeisel; Robert A Waterland; José M Ordovás; Deborah M Muoio; Wei Jia; Anthony Fodor
Journal:  JPEN J Parenter Enteral Nutr       Date:  2012-10-05       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.